Skip to main
We’re doing some system maintenance
  1. /
  2. Stocks
  3. /
  4. eFFECTOR Therapeutics Inc
EFTR

Buy EFTR Stock

EFTR
See EFTR stock price and Buy/Sell eFFECTOR Therapeutics Inc with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing
EFTR

eFFECTOR Therapeutics Inc (EFTR)

About eFFECTOR Therapeutics Inc (EFTR)

eFFECTOR Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of a new class oncology drugs known as selective translation regulator inhibitors (STRIs). Its STRI product candidates target the eIF4F complex and its activating kinase, mitogen-activated protein kinase 1/2 (MNK 1/2). The company was founded by Kevan Shokat, Davide Ruggero, and Siegfried Re...Read more
Market Cap
$23.17M
1 Year High
$17.99
Volume
96.42k
1 Year Low
$0.47
Price to Earnings Ratio
0.95
Open
$0.53
Dividend Rate
High
$0.58
Dividend Yield
Low
$0.53

Community

People who own or watch EFTR stock

EFTR Price Targets

What analysts think EFTR stock price will be.
$0.57
$20.04
3,440.6% Upside
$0$22

EFTR Stock Rating

What analysts recommend for EFTR stock, on a scale from 1(buy) to 5(sell).
Strong Buy1.4 / 5
BuyHoldSell

EFTR Stock Earnings

The value each EFTR share was expected to gain vs. the value that each EFTR share actually gained.
Expected
Actual

EFTR Stock News

Frequently Asked Questions (FAQ)

As of Sep 25, 2022, the market cap for EFTR stock is $23.17M

The current P/E ratio for EFTR stock is 0.95

The 52-week high for EFTR stock is $17.99. The current EFTR stock price $0.566 is 96.85% below its 52-week high

The 52-week low for EFTR stock is $0.47. The current EFTR stock price $0.566 has increased 16.96% from its 52-week low

No, the EFTR stock does not pay dividends to its shareholders

The target price for EFTR stock is $20.04 based on the average of what a group of analyst think EFTR stock could be worth at a future date. This is not a prediction by Public.com

Buy EFTR Stock

EFTR
See EFTR stock price and Buy/Sell eFFECTOR Therapeutics Inc with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing

Community

People who own or watch EFTR stock
  • mlbanks avatar
  • outdoorgal avatar
  • MLozyy avatar
  • kylem21 avatar
  • Davehyte avatar
Check the background of this firm on FINRA’s BrokerCheck.

© Copyright 2022 Public Holdings, Inc. All Rights Reserved.

Market data powered by Xignite.

Securities are offered to self-directed customers by Open to the Public Investing, Inc. (“Open to the Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here. Open to Public Investing is a wholly-owned subsidiary of Public Holdings Inc. (“Public Holdings”). This is not an offer, solicitation of an offer or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Open to the Public Investing is not registered. Securities products offered by Open to the Public Investing are not FDIC insured.

Cryptocurrency execution and custody services are provided by Apex Crypto LLC (NMLS ID 1828849) through a software licensing agreement between Apex Crypto LLC and Public Crypto LLC. Apex Crypto is not a registered broker-dealer or a member of SIPC or FINRA. Cryptocurrencies are not securities and are not FDIC or SIPC insured. Apex Crypto is licensed to engage in virtual currency business activity by the New York State Department of Financial Services. Please ensure that you fully understand the risks involved before trading: Legal Disclosures

Commission-free trading of stocks and ETFs refers to $0 commissions for Open to the Public Investing self-directed individual cash brokerage accounts that trade the U.S. listed securities electronically. Keep in mind, that other fees such as regulatory fees, Premium subscription fees, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Open to the Public Investing’s Fee Schedule to learn more.

All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns.